Showing 11,501 - 11,520 results of 103,675 for search '(( a step decrease ) OR ( 5 ((we decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.61s Refine Results
  1. 11501

    Image_9_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  2. 11502

    Image_7_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  3. 11503

    Image_1_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  4. 11504

    Image_6_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  5. 11505

    Image_3_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  6. 11506

    Image_2_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  7. 11507

    Image_1_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  8. 11508

    Image_6_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  9. 11509

    Image_4_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  10. 11510

    Image_4_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  11. 11511

    Image_8_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  12. 11512

    Image_2_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  13. 11513

    Image_9_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  14. 11514

    Molecular Dynamics with Chemical AccuracyAlkane Adsorption in Acidic Zeolites by Fabian Berger (8813759)

    Published 2023
    “…They show that the observed decrease of experimental apparent barriers from propane to pentane for alkane cracking in MFI (28 kJ mol<sup>–1</sup>) is largely due to increasing adsorption strengths (21 kJ mol<sup>–1</sup>) and to a much smaller extent to decreasing intrinsic barriers (7 kJ mol<sup>–1</sup>).…”
  15. 11515

    Single-Molecule Magnets:  Structural Characterization, Magnetic Properties, and <sup>19</sup>F NMR Spectroscopy of a Mn<sub>12</sub> Family Spanning Three Oxidation Levels by Nicole E. Chakov (2638930)

    Published 2005
    “…Hysteresis loops obtained from single-crystal magnetization vs DC field scans are typical of single-molecule magnets with the coercivities increasing with decreasing <i>T</i> and increasing field sweep rate and containing steps caused by the quantum tunneling of magnetization (QTM). …”
  16. 11516

    Design, Synthesis, and Biological Evaluation of New Peripheral 5HT<sub>2A</sub> Antagonists for Nonalcoholic Fatty Liver Disease by Minhee Kim (1592440)

    Published 2020
    “…Here, structural modifications of pimavanserin (CNS drug), a 5HT<sub>2A</sub> antagonist approved for Parkinson’s disease, led us to synthesize new peripherally acting 5HT<sub>2A</sub> antagonists. …”
  17. 11517
  18. 11518
  19. 11519
  20. 11520